Frequently Asked Questions (FAQs)

How often does the Beneficiary Advisory Council (BAC) meet?

The BAC will meet quarterly, online using Microsoft Teams. Attendees will be able to log on by using telephone or internet.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
How long is a Beneficiary Advisory Council (BAC) member term?

Members must be willing to serve on the BAC for two years. Regular attendance and participation is expected of all members. If more than two meetings in a row are missed, the BAC member may be replaced.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
What is the time commitment for a BAC Member?

Approximately 2-3 hours each quarter.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
How many applicants will be selected to serve on the BAC?

15 members will be selected.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
Who should apply to be a BAC member?

We want the BAC to reflect the diversity of New Mexico’s members, including:

  • People from various racial and ethnic backgrounds found in New Mexico,
  • English language learners,
  • Parents of young children,
  • Young adults,
  • People with disabilities,
  • Individuals who use behavioral health services,
  • Residents from urban, rural, and frontier areas of New Mexico,
  • Members from New Mexico’s Tribes, Pueblos, and Nations, and
  • Dual eligibility members (who are enrolled in Medicaid and Medicare)
DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
How do I apply to be a BAC member?

Applications are currently closed for the BAC and will reopen every year to welcome new members.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
How are council members chosen?
DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
When will you decide on who is accepted as a BAC member?

Applications will be reviewed, and members will be notified June 30, 2025.

DivisionMedical Assistance Division (MAD)
ProgramBeneficiary Advisory Council (BAC)
Who must file under the Health Care Consolidation Oversight Act?

All licensed hospitals and certain health care provider organizations (as defined in the legislation) proposing a merger, acquisition, or change in majority ownership/control must submit a Transaction Notice to DHI before closing.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
What is considered a transaction under the Health Care Consolidation Oversight Act?

The Health Care Consolidation Act applies to any “transaction,” defined as:

1. A merger of one hospital into another;
2. An acquisition of a hospital by another entity; or
3. A change of control of hospital ownership or real estate.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
When is my submission considered “complete”?

You’ll have 30 days from the initial filing to respond to any requests for missing information. A submission becomes “complete” once HCA has received all required documents, exhibits, and fees.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
What happens if I miss the public forum?

You can still submit written comments through the end of the comment period. All submissions—oral or written—are given equal weight in HCA’s review.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
Who pays for expert consultants and review costs?

The Health Care Consolidation Oversight Act authorizes HCA to retain specialized consultants—such as actuaries, financial analysts, or legal experts—to assist with complex transaction reviews. The hospital (or transaction parties) is responsible for reimbursing the HCA’s actual costs for these services.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
How do I appeal an HCA decision?

If HCA denies or conditions your transaction, you may request a contested-case hearing under the Uniform Licensing Act (U.L.A.) within 30 days of the decision notice.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
Can confidential or proprietary information be protected?

Yes. All documents you file with HCA are treated as confidential under the Health Care Consolidation Oversight Act. If you believe certain exhibits should remain proprietary, clearly mark them “CONFIDENTIAL” and file a redacted public version.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
How long will the review take?

Once your submission is complete, HCA has 120 days to issue a decision. Complex transactions or those flagged as “urgent” may follow an accelerated schedule at HCA’s discretion.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
What’s required in the annual post-transaction report?

For three years following your transaction, you’ll submit yearly updates on financial performance, service volumes, community benefit activities, and any material changes—using the format HCA provides. You can fill out and submit the report form HERE. You will also need to include THIS FORM in your submission.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
How can I submit an annual report?

You can fill out the annual report form HERE. You will also need to fill out and inlcude THIS FORM in the submission.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
What penalties apply if a hospital fails to comply with, or violates, HCA’s recommendations?

Under the Health Care Consolidation Oversight Act, HCA may impose administrative fines on hospitals or transaction parties that knowingly violate filing requirements, proceed with a transaction without approval, or fail to comply with conditions. Fines are assessed on a per‑bed or per‑member basis (as specified in the administrative rules) and revenues are directed to the New Mexico School Fund.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
Where can I find the definitions for terms contained in the act?

You can find a full list of definitions of terms contained in the act HERE.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
Are there whistleblower protections for individuals who report violations?

Yes. The Health Care Consolidation Oversight Act includes safeguards for individuals who report improper or undisclosed transactions. Whistleblowers may submit information confidentially to the HCA and are protected from retaliation. Any fine revenue collected from violations stemming from a whistleblower report also supports the School Fund.

DivisionDivision of Health Improvement (DHI)
ProgramHealth Care Consolidation Oversight Act
Do pharmacies have to enroll and bill Medicaid independently for medications dispensed to Medicaid members by the pharmacy?

Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
How should carceral facilities bill for medication dispensed or administered to Medicaid members by the medical providers?

Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Can bulk medications (i.e. medications purchased as stock rather than individual prescriptions) be re-packaged for individuals to meet the requirements of medications in-hand upon release?

Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Can the pharmacy bull Medicaid for all the bulk medications it stocks?

No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Can the pharmacy bill Medicaid for medications that are not on the Medicaid Formulary?

No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Do pharmacy providers have to bill using the pharmacy point-of-sale system for 30-day meds in hand?

Yes. pharmacy providers are required to submit claims through the point-of-sale system. The point-of-sale system provides relevant drug utilization information that the pharmacist must consider before dispensing a drug. Pharmacies must follow the NM FFS Payer Sheet. The BIN for JUST Health Plus members is 028165, and pharmacy software systems must be updated accordingly so that patient profiles can reflect the new BIN. Additionally, pharmacies must have POS equipment capable of billing D.0 transactions to ensure claims can be received, processed, and sent for payment in the Turquoise Care System.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Can facilities continue to purchase under 340B special pricing for medications that will be billed to Medicaid?

Yes. Carceral facilities with 340B-acquired medications must identify 340B participation and pricing on claims by using modifiers “UD” or “08” when billing Medicaid for the applicable medications. Please refer to Provider Supplement 20-04 for further instructions on billing for 340B-acquired medications.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
If a member receives a medication in-hand upon release and is re-incarcerated and released again (e.g. 1-2 weeks following the first release), is the facility required to provide medication in-hand upon release again?

HCA expects the ordering provider to determine clinical appropriateness of a new prescription. Providers have the option of overriding a “Fill too Soon” rejection. If utilization information indicates that the member has an adequate supply of the medication or that the quantity being dispensed is excessive, the pharmacist is responsible for resolving the issue by seeking an authorization to dispense the drug, if necessary.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)
Can facilities release a member with an electronic prescription for a 30-day supply of medication, or do the medications have to be provided in-hand at the time of release?

The requirement is to provide up to a 30-day supply of the medications in-hand, as clinically appropriate except as outlined below. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release.

DivisionMedical Assistance Division (MAD)
ProgramJustice-involved Utilization of State Transitioned Healthcare (JUST Health)